Glenmark launches FDC of Teneligliptin + Pioglitazone + Metformin EP News Bureau Dec 21, 2022 The triple FDC will help improve glycemic control among adults with High HbA1c and high insulin resistance, those whose diabetes…
Drug used to treat opioid addiction can reverse some adverse events caused by type 2 diabetes: Study EP News Bureau Nov 2, 2020 IIT Mandi researchers find that low-dose naltrexone (LDN) can activate SIRT1, a critical protein molecule, thereby reducing…
